Skip to content

Brimonidine Nitroso Impurity

Brimonidine Nitroso Impurity

Product Description
CAT No.
ALN-B026032
CAS No.
NA
Mol. F.
C11H9BrN6O
Mol. Wt.
321.1
Stock
Please Inquire
RFQ
Chemical Name : 5-Bromo-N-(1-nitroso-4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
Smiles : BrC1=C2N=CC=NC2=CC=C1NC3=NCCN3N=O
Inchi : InChI=1S/C29H38ClN8O3P/c1-35-15-17-37(18-16-35)21-11-13-36(14-12-21)22-9-10-24(26(19-22)41-2)32-29-31-20-23(30)28(33-29)38(34-39)25-7-5-6-8-27(25)42(3,4)40/h5-10,19-21H,11-18H2,1-4H3,(H,31,32,33)

Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma

B.Chianga1Y.C.Kimb1A.C.Dotyc12H.E.GrossniklausdS.P.SchwendemancM.R.PrausnitznJournal of Controlled Release Volume 228, 28 April 2016, Pages 48-57

Sustained release of brimonidine from a new composite drug delivery system for treatment of glaucoma

Jianguo Sun, Yuan Lei, Zhaoxing Dai∥, Xi Liu, Taomin Huang, Jihong Wu, Zhi Ping XOrcid, and Xinghuai Sun – ACS Appl. Mater. Interfaces 2017, 9, 9, 7990–7999

A validated stability-indicating HPLC method for determination of brimonidine tartrate in BRI/PHEMA drug delivery systems

Jianguo Sun, Xiuwen Zhang & Taomin Huang – Chemistry Central Journal volume 11, Article number: 62 (2017)

Request For Quotation

Related Products